Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-001604
Filing Date
2024-01-19
Accepted
2024-01-19 16:28:37
Documents
1
Period of Report
2024-01-18

Document Format Files

Seq Description Document Type Size
1 form4-01192024_090131.html 4  
1 form4-01192024_090131.xml 4 5838
  Complete submission text file 0001415889-24-001604.txt   7426
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Noonberg Sarah B. (Reporting) CIK: 0001706301 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 24545958